Outcome of childhood leukaemia survivors and necrosis of the femoral head treated with autologous mesenchymal stem cells.
T de RojasS Martínez-ÁlvarezS Lerma-LaraM Á DíazL MaderoManuel RamírezPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2017)
Our preliminary results suggest that autologous MSCs can be considered as a novel treatment for children and young adults with ON after overcoming ALL. It may avoid hip replacement and improve quality of life of leukaemia survivors.